To find anti-inflammatory compounds from the tuberous roots of Dioscorea batatas, we isolated 6-hydroxy-2,4,7-trimethoxyphenanthrene (batatasin I) from the dichloromethane (CH 2 Cl 2 ) fraction of this plant. Batatasin I inhibited both the generation of prostaglandin D 2 (PGD 2 ), leukotriene C 4 (LTC 4 ) and degranulation reaction in mouse bone marrow-derived mast cells (BMMCs). This compound inhibited cyclooxygenase-2 (COX-2) dependent PGD 2 generation in a dose dependent manner, with IC 50 values of 1.78 m mM. Western blotting probed with specific anti-COX-2 antibodies showed that the decrease in the quantity of the PGD 2 generation was accompanied by a decrease in the COX-2 protein level. In addition, this compound also inhibited the production of 5-lipoxygenase (5-LOX) dependent LTC 4 in a dose dependent manner (IC 50 , 1.56 m mM). Batatasin I also inhibited the mast cell degranulation reaction (IC 50 , 6.7 m mM) in BMMCs. This result indicates that batatasin I could be developed as an anti-inflammatory agent through further investigation.
Mast cells (MCs) are involved in the pathophysiology of inflammation and immediate-type allergic reactions. MCs are activated by allergen-specific immunoglobulin E (IgE) binding, with its high-affinity IgE receptor (FceRI) or Stem Cell Factor (SCF, also known as c kit-ligand, KL) to c-Kit, MCs release various preformed chemical mediators and newly synthesized inflammatory mediators. During the early phase of a reaction, MCs release histamine, tryptase, prostaglandin D 2 (PGD 2 ), leukotriene C 4 (LTC 4 ), platelet-activating factor, chemokine, tumor necrosis factor and various other interleukins. [1] [2] [3] The enzymes responsible for PG synthesis, cyclooxygenases (COXs), are now known to exist as two isoforms, COX-1 and COX-2.
4) COX-1 is constitutively expressed in majority of the cells and tissues and is the major isoform seen in gastrointestinal tissue, whereas COX-2 is an inducible isozyme, the expression of which is elevated in response to inflammatory cytokines and endotoxin. 5, 6) The discovery of COX-2 led to the new concept that selective inhibition of COX-2 activity explains both the therapeutic benefits and the side effects associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs), whereas inhibition of COX-1 is responsible for their gastric and renal side effects as well as for their antithrombotic activity. However, the role of COX-1 in inflammation 7) and sudden cardiac arrest and other dangerous side effects associated with selective COX-2 inhibitors cannot be excluded. 8, 9) LTC 4 , another class of inflammatory lipid mediators, are synthesized from arachidonic acid by the action of 5-lipoxygenase (5-LOX) in mast cells, eosionophils, and monocytes'.
10) The development of dual inhibitors that can simultaneously inhibit COX-2 and 5-LOX might synergistically inhibit inflammation and reduce the undesirable side effects that are commonly associated with non steroidal anti-inflammatory drugs (NSAIDs).
11)
The rhizome of Dioscorea (D.) batatas is widely distributed in East Asia, including Korea, China, Japan and Taiwan. Plants of the genus D. batatas have long been used in oriental folk medicine, and D. batatas has been cultivated as a health food in Korea. Phytochemical constituents of D. batatas such as polysaccharide, 12) storage protein, 12, 13) mannose-binding lectin, 14) steroidal saponin, 15, 16) and phenanthrene derivatives. [17] [18] [19] Different scientists have reported different biological activities of D. batatas such as anti-oxidative, 21, 22) cholesterol-lowering, 23) anti-cholinesterase activity, 24) anti-inflammatory activity, 24) growth hormone-releasing activity, 25) antifungal activity of phenanthrene compounds [17] [18] [19] and immune cell-stimulating activity. 26) Previously, our group reported anti-inflammatory activity of D. batatas in LPS stimulated RAW264.7 cells. 27) In the course of isolating the active compound(s) from this plant 6-hydroxy-2,4,7-trimethoxyphenanthrene (batatasin I) was isolated from the dichloromethane (CH 2 Cl 2 ) fraction of the tuberous roots of this plant and its anti-inflammatory activity was evaluated. Even though, the antifungal activity of batatasin I had been reported elsewhere, 18, 19) the exact mechanisms of the anti-inflammatory effects of batatasin I have not been reported till date. Therefore, for the first time, we have investigated anti-inflammatory activity of batatasin I on the production of eicosanoid generation as well as degranulation in SCF-treated BMMCs.
MATERIALS AND METHODS

Plant Material
The dried tuberous roots (9.5 kg) were extracted with methanol (MeOH) under reflux 3 times and the filtrate was concentrated under reduced pressure to give a MeOH extract (631 g). The MeOH extract was suspended in C-NMR data with those reported previously. 19) Batatasin I used in this study showed a single spot on TLC and the purity of this compound is above 99.5% based on HPLC analysis. Batatasin I was prepared by dissolving in dimethyl sulfoxide (DMSO) and final concentrations of DMSO were adjusted to 0.1% (v/v) in culture media. Control with DMSO alone was run in all cases.
Preparation and Activation of BMMCs BMMCs isolated from male Balb/cJ mice (Sam Taco, Inc., Seoul) were cultured in 20% PWM-SCM (pokeweed mitogen-spleen cell conditioned medium) as a source of interleukin-3 (IL-3). After 3 weeks, Ͼ98% of the cells was found to be BMMCs checked by the previously described procedure.
5)
Determination of Prostaglandin D 2 (PGD 2 ) For measuring inhibitory activity on COX-2 by MeOH, CH 2 Cl 2 fraction, batatasin I and licofelone (Toronto Research Chemicals Inc., North York, ON, Canada). BMMCs suspended at a cell density of 5ϫ10 5 cells/ml in enriched medium were preincubated with aspirin (10 mg/ml) for 2 h in order to irreversibly inactivate preexisting COX-1. After washing, BMMCs were activated with SCF (100 ng/ml, STEMCELL Technologies Inc., Vancouver, BC, Canada), interleukin (IL)-10 (100 U/ml) and lipopolysaccharide (LPS, 100 ng/ml) at 37°C for 8 h with or without MeOH, CH 2 Cl 2 fraction and batatasin I previously dissolved in DMSO. All reactions were stopped by centrifugation at 120 g at 4°C for 5 min. The supernatant and cell pellet were immediately frozen in liquid N 2 and stored at Ϫ80°C for further analysis. Concentrations of PGD 2 in the supernatant were measured using PGD 2 assay kit (Cayman Chemical, Ann Arbor, MI, U.S.A.) according to manufacturer's instruction. In this assay conditions, COX-2-dependent phases of PGD 2 generation reached approximately 5.5 ng/10 6 cells. All data was the arithmetic mean of triplicate determinations.
Determination of Leukotriene C 4 (LTC 4 ) BMMCs suspended in enriched medium at a cell density of 1ϫ10 6 cells/ml were pretreated with MeOH, CH 2 Cl 2 fraction, batatasin I and licofelone for 15 min at 37°C and stimulated with SCF (100 ng/ml). After 20 min of stimulation, the supernatants were isolated for further analysis by EIA. LTC 4 was determined using an enzyme immunoassay kit (Cayman Chemical, Ann Arbor, MI, U.S.A.) according to the manufacturer's instruction. Under the conditions employed, the amount of LTC 4 reached approximately 23 ng/10 6 cells. All data was the arithmetic mean of triplicate determinations.
Assay of b b-Hexosaminidase Release b-Hexosaminidase (b-Hex), a marker of mast cell degranulation, was quantified by spectrophotometric analysis of the hydrolysis of substrate (p-nitrophenyl-2-acetamido-2-deoxy-b -D-glucopyranoside, Sigma-Aldrich). Briefly, 25 ml of cell-free supernatants were mixed with 50 ml of substrate in 0.1 M citrate, pH 4.5. After incubation for 1 h at 37°C, 175 ml of stop solution (0.2 M NaOH-glycine) was added to stop the reaction, and absorbance was measured at 405 nm. Values were expressed as percentage release relative to total b-Hex in the cells. All data was the arithmetic mean of triplicate determinations.
Preparation of Nuclear and Cytosolic Extracts Cell pellets were resuspended in wash buffer containing 10 mM N-(2-hydroxyethyl)piperazine-NЈ-2-ethanesulfonic acid (HEPES) buffer (pH 8.0), 1.5 mM MgCl 2 , 10 mM KCl, 1 mM phenylmethylsufonyl fluoride and 1 mM protease inhibitor cocktail (La Jolla, CA, U.S.A.), and then lysed in lysis buffer A containing wash buffer with 0.1% NP40 by incubating on ice for 10 min. Lysates were then centrifuged at 1000 g for 5 min. Supernatants were removed and stored at Ϫ70°C as a cytosolic fraction. Nuclear pellets were washed with wash buffer and resuspended in buffer B containing 20 mM HEPES (pH 8.0), 25% glycerol, 420 mM NaCl, 1.5 mM MgCl 2 , and 0.2 mM ethylenediaminetetraacetic acid (EDTA), and the protease inhibitor cocktail. This suspension was incubated for 30 min at 4°C followed by centrifugation at 10000 g.
Sodium Dodecyl Sulfate (SDS) Polyacrylamide Gel Electrophoresis/Immunoblot Analysis After activation with SCF, IL-10 and LPS, BMMCs (1ϫ10 7 cells/ml) were washed once with 10 mM phosphate buffer (pH 7.4) containing 150 mM NaCl (phosphate buffered saline (PBS)) and lysed in PBS containing 0.1% SDS and 10 mM b-mercaptoethanol. The lysate (1ϫ10 5 cells equivalent) was applied to 10% SDS-polyacrylamide gels. After running the gel, the protein bands were blotted onto nitrocellulose membranes (Schleicher and Schull, Dassel, Germany) using a semi-dry blotter (MilliBlot-SDE system, Millipore, Bedford, MA, U.S.A.) according to the manufacturer's instructions. Membranes were then washed once with 10 mM Tris-buffered saline (TBS, pH 7.2) containing 0.1% tween-20 (TBS-T), and then blocked for 1 h in TBS-T containing 3% skim milk. After washing the membranes with TBS-T, an antibody directed against COX-2, phospho-cPLA 2 , phospho-PLCg1 and 5-LOX were added at a dilution of 1 : 3000-5000 in TBS-T. After incubation for 2 h followed by washing three times, membranes were treated for 1 h with horseradish peroxideconjugated goat anti-rabbit IgG (Zymed, South San Francisco, CA, U.S.A.) (diluted to 1 : 7000) in TBS-T. The protein bands were visualized using an enhanced chemiluminesence (ECL) system (Amersham Corp., Newark, NJ, U.S.A.).
Statistical Analysis All values are represented as arithmetic meansϮS.D. One-way analysis of variance (ANOVA) was utilized to determine the statistical significance. Linear regression analysis was conducted to calculate the IC 50 value.
RESULTS AND DISCUSSION
In our ongoing search for anti-inflammatory compounds from the D. batatas, we found that the CH 2 Cl 2 fraction (100 mg/ml) strongly inhibited COX-2 dependent PGD 2 (99.6%) in SCF/LPS/IL-10 treated BMMCs, 5-LOX dependent LTC 4 generation (58.9%) and degranulation reaction (85.3%) in SCF-treated BMMCs. In addition, the inhibition of PGD 2 generation was accompanied by the inhibition of COX-2 protein expression (Fig. 1) . This result led us to search active compound(s) from the CH 2 Cl 2 fraction of the D. batatas. Repeated normal-phase silica gel column chromatographies of the CH 2 Cl 2 fraction lead to the isolation of 6-hydroxy-2,4,7-trimethoxyphenanthrene (batatasin I) (Fig. 2) . We first examined the cytotoxicic effect of batatasin I on BMMCs using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and found that it did not affect cell viability at 8 mM (data not shown). Therefore, batatasin I at concentrations of Ͻ8 mM were used for subsequent experiments. BMMCs exhibited a biphasic PGD 2 biosynthetic response over time. Immediate PGD 2 generation, defined as occurring within 2 h, is associated with the activation of COX-1, and delayed PGD 2 generation, which is seen following several hours of culturing (2-10 h), is associated with the de novo induction and function of COX-2 after stimulation with IgE/ Ag or cytokines and LPS stimulation. 28, 29) It is well known that PGD 2 is the major prostanoid secreted from the activated mast cell and has long been implicated in the etiology and manifestation of inflammation and allergic diseases. 30) Recently, Yang et al. reported biological function of several phenolic compounds including batatasin III and batatasin IV from Dioscorea opposite. They showed that batatasin III and batatasin IV exhibited radical scavenging activities, but these two compounds did not show COX-2 enzyme inhibitory activity. 31 ) Therefore, we investigated the effects of batatasin I on COX-2 dependent PGD 2 generation in SCF, IL-10 and LPS treated BMMCs. 32, 33) Following activation of BMMCs by the combination of SCF, IL-10 and LPS with or without batatasin I, COX-2 dependent PGD 2 generation was inhibited in a dose-dependent manner with an IC 50 value of approximately 1.78 mM (Fig. 3A) . The inhibitory effect of the batatasin I on PGD 2 production was examined to determine the direct effects are mediated by COX-2 protein expression. The effects of batatasin I on the COX-2 protein expression were determined by Western blot test, probed with specific anti-COX-2 antibody. As shown in Fig. 3B , COX-2 protein was not detected in unstimulated BMMCs, whereas cytokine combination stimulated BMMCs induce the expression of detectable COX-2 protein and COX-2 protein expression was inhibited in a dose-dependent manner by batatasin I. The inhibitory effect of the highest concentration of batatasin I was comparable to that of licofelone (COX-2/5-LOX dual inhibitor) which was used as a positive control. 34) These results clearly demonstrated that decrease in the PGD 2 generation was accompanied by a decrease in the COX-2 protein level.
LTs are key lipid mediator that are significantly involved in immunoregulation and elevated in a variety of diseases, including asthma, inflammation and various allergic conditions. When activated by diverse stimuli, the mast cells release arachidonic acid through phospholipase A 2 (PLA 2 ), and rapidly generate both PGD 2 and the parent molecule of the cysteinyl leukotrienes (LTC 4 , LTD 4 and LTE 4 ). 6 ) LTC 4 is metabolites of arachidonic acid derived from action of 5-LOX/LTC 4 synthase in mast cells, and LTC 4 is a family of eicosanoid lipid mediators have been implicated in inflammation, proliferation and allergic conditions like asthma. [35] [36] [37] [38] The development of a specific inhibitor for 5-LOX would not only be useful as a tool in investigating the regulatory mechanism behind LT biosynthesis, it can also be utilized for therapeutic purposes.
39) Thus, we investigated the effects of batatasin I on 5-LOX dependent LTC 4 generation in BMMC. Figure 4 shows that the BMMC stimulated with SCF for 15 min produced approximately 23 ng/10 6 cells, and batatasin I strongly inhibited this LTC 4 biosynthesis in a dose-dependent manner with an IC 50 value of approximately 1.56 mM. The inhibitory effect of 5 mM batatasin I was comparable to that of licofelone. Biosynthesis of LTC 4 in mast cells is initiated by the oxygenation of free arachidonic acid (AA) via 5-LOX, and the liberation of AA from membrane is regulated by activated calcium dependent 85-kDa cytosolic PLA 2 a BMMCs were pre-incubated for 1 h with the 100 mg/ml of CH 2 Cl 2 fraction and then stimulated with SCF (100 ng/ml), IL-10 (100 U/ml), and LPS (200 ng/ml) at 37°C for 8 h with or without CH 2 Cl 2 fraction. Fig. 2 . Chemical Structure of 6-Hydroxy-2,4,7-trimethoxyphenanthrene (Batatasin I) Fig. 3 . Effect of Batatasin I and Licofelone on COX-2-Dependent PGD 2 
Generation and COX-2 Protein Expression
BMMCs were pre-incubated for 1 h with the various concentration of batatasin I and 10 mM licofelone, then stimulated with SCF (100 ng/ml), IL-10 (100 U/ml), and LPS (200 ng/ml) at 37°C for 8 h with or without batatasin I or licofelon. PGD 2 released into the supernatant was quantified using an EIA kit. Samples were processed by SDS-PAGE and transferred to a nitrocellulose filter. The immunoblot was then probed with anti-COX-2 at a dilution 1 : 3000 (A). The procedures are described in Materials and Methods in detail. The relative ratio (%) of COX-2 protein expression and b-actin protein level was determined by measuring immunoblot band intensities by scanning densitometry (B). The values are expressed as the meansϮS.D. of three individual experiments. * pϽ0.05, * * pϽ0.01 and * * * pϽ0.001 indicate significant differences from the cytokine-treated group. Licofelone was used as an COX-2/5-LOX dual inhibitor control agent.
(cPLA 2 a). Translocation of 5-LOX and phospho-cPLA 2 a to the nuclear membrane are required for the generation of LTC 4 . 38) To investigate the mechanism of batatasin I on the LTC 4 generation, we examined whether batatasin I affects phosphorylation of cPLA 2 a and translocation of both phosphorylated cPLA 2 a and 5-LOX to the nuclear membrane. As shown in Figs. 5A and B, batatasin I dose-dependently inhibited not only phosphorylation of cPLA 2 a but also translocation of phosphorylated cPLA 2 a (nuclear-p-cPLA 2 a) and 5-LOX (nuclear-5-LOX). This result showed that inhibition of LTC 4 generation by batatasin I occurred through the attenuation of translocation of phosphorylated cPLA 2 a and 5-LOX. COX-2/5-LOX dual inhibitors might synergistically inhibit inflammation and avoids some of the disadvantages of selective COX-2 inhibitors and spares the gastrointestinal mucosa. [39] [40] [41] This results clearly demonstrate that batatasin I has COX-2/5-LOX dual inhibitory activity and might be good candidate for develop COXs/5-LOX dual inhibitors.
When mast cells are activated by various stimuli, the release of histamine bears a close parallel to that of b-hexosaminidase (b-Hex), which is one of degranulation markers. Therefore, the inhibitory activity of batatasin I on the degranulation reaction in the BMMCs was examined. As shown in Fig. 6 , batatasin I inhibited the dose-dependent inhibition of b-Hex release with an IC 50 value of 2.7 mM. Since intracellular calcium mobilization was a necessary signal for degranulation of mast cells, we examined the effect of batatasin I on the phosphorylation of phospholipase Cg1 (PLCg1). PLCg1 phosphorylation activates generation of inositol-3 phosphate, which triggers subsequent activation of calcium signals. As demonstrated in Fig. 6 , batatasin I significantly inhibited the tyrosine phosphorylation of PLCg1 in a dose-dependent manner.
Previously other groups reported that D. batatas induced occupational asthma and rhinitis caused, as confirmed by specific inhalation challenge tests. 42, 43) However, the results of this study strongly suggest that batatasin I showed antiinflammatory effects via the inhibition of both eicosanoid generation and degranulation reaction in activated mast cells. SCF has been shown to induce histamine release of mature connective tissue-type mast cells as well as to induce directly mast cell chemotaxis. 44, 45) In addition, SCF induce airway hyperreactivity in allergic and normal mice. 46) Further, SCF BMMCs were pre-incubated for 1 h with the indicated concentrations of batatasin I and then stimulated with 100 ng/ml SCF for 15 min. b-Hex released into the supernatant was measured and the cells were harvested for measurements of phosphorylated PLCg1 by Western blot analysis. The relative ratio (%) of phospho-PLCg1/b-actin protein level was determined by measuring immunoblot band intensities by scanning densitometry. All data are the arithmetic mean of triplicate determinations. * pϽ0.05 and * * pϽ0.01 indicate significant differences from the SCF-treated group. BMMCs were pre-incubated for 1 h with the indicated concentrations of batatasin I and licofelone, then more stimulated with SCF (100 ng/ml) for 15 min. LTC 4 released into the supernatant was quantified using an enzyme immunoassay kit. All data are the arithmetic mean of triplicate determinations. * pϽ0.05 and * * pϽ0.01 indicate significant differences from the SCF-treated group. Licofelone was used as COX-2/5-LOX dual inhibitor control agent.
is an important role in the pathophysiology of asthma and inhibition of SCF attenuates chronic allergen-induced asthma. 47, 48) Taken together, the present study suggests batatasin I represents a potential therapeutic approach in the treatment of an airway allergic-inflammatory diseases.
